soared 11.64% to $27.04 Tuesday after the healthcare services company beat Wall Street's fourth-quarter earnings expectations. The Dallas-based company reported a loss $5 million, or 5 cents a share, compared with a year-earlier loss of $230 million, or $2.27 a share. Revenue for the quarter came in at $4.62 billion, down 7.2% from a year ago, but beat the consensus estimate of $4.51 billion.